SCHEMBL2328836

SCHEMBL2328836

CC(CNC(=O)C(N)=O)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.55
▸ RAB9A P51151 1/20 0.55
▸ AOC3 Q16853 1/20 0.55
▸ TAAR1 Q96RJ0 4/20 0.51
▸ BCAT2 O15382 1/20 0.49
▸ APAF1 O14727 1/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ TP53 P04637 2/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ BCL2 P10415 2/20 0.43
▸ BCL2L1 Q07817 2/20 0.43
▸ MCL1 Q07820 2/20 0.43
▸ BCL2A1 Q16548 2/20 0.43
▸ BAK1 Q16611 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2328840 1.00 NPC1 (0.55) NPC1RAB9AAOC3TAAR1BCAT2
SCHEMBL2432247 0.86 BCAT2 (0.66) NPC1RAB9AAOC3TAAR1BCAT2
SCHEMBL28710854 0.84 LMNA (0.55) NPC1RAB9ABCAT2APAF1MEN1
SCHEMBL4530460 0.82 NPC1 (0.61) NPC1RAB9AAOC3TAAR1APAF1
SCHEMBL8384245 0.80 MTNR1A (0.60) NPC1RAB9AAOC3TAAR1APAF1
SCHEMBL8384291 0.80 MTNR1A (0.60) NPC1RAB9AAOC3TAAR1APAF1
SCHEMBL2091303 0.80 MTNR1A (0.60) NPC1RAB9AAOC3TAAR1APAF1
Hydrochloric Acid SCHEMBL4323386 0.80 TAAR1 (0.60) NPC1RAB9AAOC3TAAR1APAF1
SCHEMBL4590879 0.79 LMNA (0.54) BCAT2MEN1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL27901634 0.79 OPRM1 (0.56) NPC1RAB9AMEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2210607-B1 N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer EXELIXIS INC (US) 2011-08-17 — — EP disclosed
Send feedback